ATRA - Atara Biotherapeutics, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 5492.59M
Enterprise value 3211.37M
Trailing P/E N/A
Forward P/E 1-1.84
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)1.64
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 6-0.73

Trading information

Stock price history

Beta (5Y monthly) 2.50
52-week change 3-78.53%
S&P500 52-week change 3-4.79%
52-week high 337.42
52-week low 34.52
50-day moving average 39.85
200-day moving average 313.06

Share statistics

Avg vol (3-month) 3684.97k
Avg vol (10-day) 3680.95k
Shares outstanding 558.57M
Float 33.12M
% held by insiders 12.38%
% held by institutions 1108.90%
Shares short (12 Mar 2020) 49.75M
Short ratio (12 Mar 2020) 414.78
Short % of float (12 Mar 2020) 430.05%
Short % of shares outstanding (12 Mar 2020) 416.64%
Shares short (prior month 13 Feb 2020) 49.32M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)30 Dec 2019

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-50.30%
Return on equity (ttm)-92.43%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -288.54M
Net income avi to common (ttm)-290.98M
Diluted EPS (ttm)-5.67
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)259.11M
Total cash per share (mrq)4.42
Total debt (mrq)15.96M
Total debt/equity (mrq)5.49
Current ratio (mrq)7.43
Book value per share (mrq)5.12

Cash flow statement

Operating cash flow (ttm)-235.63M
Levered free cash flow (ttm)-137.95M
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more